Logo image of ALVIN.PA

VINPAI SAS (ALVIN.PA) Stock Fundamental Analysis

EPA:ALVIN - Euronext Paris - Matif - FR001400AXT1 - Common Stock - Currency: EUR

3.48  +0.01 (+0.29%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to ALVIN. ALVIN was compared to 63 industry peers in the Chemicals industry. ALVIN may be in some trouble as it scores bad on both profitability and health. ALVIN is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ALVIN had negative earnings in the past year.
In the past year ALVIN has reported a negative cash flow from operations.
ALVIN had negative earnings in each of the past 5 years.
In the past 5 years ALVIN always reported negative operating cash flow.
ALVIN.PA Yearly Net Income VS EBIT VS OCF VS FCFALVIN.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 -1M -2M -3M

1.2 Ratios

With a Return On Assets value of -38.79%, ALVIN is not doing good in the industry: 85.71% of the companies in the same industry are doing better.
ALVIN's Return On Equity of -423.10% is on the low side compared to the rest of the industry. ALVIN is outperformed by 90.48% of its industry peers.
Industry RankSector Rank
ROA -38.79%
ROE -423.1%
ROIC N/A
ROA(3y)-24.18%
ROA(5y)-109.22%
ROE(3y)-213.23%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALVIN.PA Yearly ROA, ROE, ROICALVIN.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 -200 -400 -600

1.3 Margins

The Gross Margin of ALVIN (9.75%) is worse than 74.60% of its industry peers.
ALVIN's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for ALVIN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 9.75%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.77%
GM growth 5YN/A
ALVIN.PA Yearly Profit, Operating, Gross MarginsALVIN.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 -50 -100 -150 -200

More info and screens

0

2. Health

2.1 Basic Checks

ALVIN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ALVIN has been increased compared to 1 year ago.
Compared to 1 year ago, ALVIN has an improved debt to assets ratio.
ALVIN.PA Yearly Shares OutstandingALVIN.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 1M 2M 3M
ALVIN.PA Yearly Total Debt VS Total AssetsALVIN.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2M 4M 6M 8M

2.2 Solvency

ALVIN has an Altman-Z score of -0.01. This is a bad value and indicates that ALVIN is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.01, ALVIN is doing worse than 80.95% of the companies in the same industry.
A Debt/Equity ratio of 4.18 is on the high side and indicates that ALVIN has dependencies on debt financing.
ALVIN's Debt to Equity ratio of 4.18 is on the low side compared to the rest of the industry. ALVIN is outperformed by 88.89% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.18
Debt/FCF N/A
Altman-Z -0.01
ROIC/WACCN/A
WACC6.78%
ALVIN.PA Yearly LT Debt VS Equity VS FCFALVIN.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 2M -2M 4M

2.3 Liquidity

A Current Ratio of 0.67 indicates that ALVIN may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.67, ALVIN is doing worse than 88.89% of the companies in the same industry.
ALVIN has a Quick Ratio of 0.67. This is a bad value and indicates that ALVIN is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.44, ALVIN is not doing good in the industry: 88.89% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.67
Quick Ratio 0.44
ALVIN.PA Yearly Current Assets VS Current LiabilitesALVIN.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 1M 2M 3M 4M

More info and screens

7

3. Growth

3.1 Past

ALVIN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -57.97%.
ALVIN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 18.07%.
ALVIN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 21.64% yearly.
EPS 1Y (TTM)-57.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-11.42%
Revenue 1Y (TTM)18.07%
Revenue growth 3Y21.64%
Revenue growth 5YN/A
Sales Q2Q%18.59%

3.2 Future

ALVIN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 30.69% yearly.
The Revenue is expected to grow by 27.77% on average over the next years. This is a very strong growth
EPS Next Y93.95%
EPS Next 2Y46.67%
EPS Next 3Y30.69%
EPS Next 5YN/A
Revenue Next Year19.94%
Revenue Next 2Y26.63%
Revenue Next 3Y27.77%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALVIN.PA Yearly Revenue VS EstimatesALVIN.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 5M 10M 15M
ALVIN.PA Yearly EPS VS EstimatesALVIN.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 0 0.05 -0.05 0.1 0.15 0.2

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALVIN. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 22.52 indicates a rather expensive valuation of ALVIN.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ALVIN is on the same level as its industry peers.
ALVIN's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.10.
Industry RankSector Rank
PE N/A
Fwd PE 22.52
ALVIN.PA Price Earnings VS Forward Price EarningsALVIN.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALVIN.PA Per share dataALVIN.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

ALVIN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ALVIN's earnings are expected to grow with 30.69% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y46.67%
EPS Next 3Y30.69%

More info and screens

0

5. Dividend

5.1 Amount

ALVIN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

VINPAI SAS

EPA:ALVIN (3/7/2025, 7:00:00 PM)

3.48

+0.01 (+0.29%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners43.86%
Ins Owner ChangeN/A
Market Cap12.04M
Analysts40
Price Target4.59 (31.9%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 22.52
P/S 1.39
P/FCF N/A
P/OCF N/A
P/B 12.97
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.17
EYN/A
EPS(NY)0.15
Fwd EY4.44%
FCF(TTM)-1.08
FCFYN/A
OCF(TTM)-1.02
OCFYN/A
SpS2.5
BVpS0.27
TBVpS-0.74
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -38.79%
ROE -423.1%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 9.75%
FCFM N/A
ROA(3y)-24.18%
ROA(5y)-109.22%
ROE(3y)-213.23%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.77%
GM growth 5YN/A
F-Score3
Asset Turnover0.85
Health
Industry RankSector Rank
Debt/Equity 4.18
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 30.24%
Cap/Sales 2.3%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.67
Quick Ratio 0.44
Altman-Z -0.01
F-Score3
WACC6.78%
ROIC/WACCN/A
Cap/Depr(3y)58.56%
Cap/Depr(5y)N/A
Cap/Sales(3y)4.15%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-57.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-11.42%
EPS Next Y93.95%
EPS Next 2Y46.67%
EPS Next 3Y30.69%
EPS Next 5YN/A
Revenue 1Y (TTM)18.07%
Revenue growth 3Y21.64%
Revenue growth 5YN/A
Sales Q2Q%18.59%
Revenue Next Year19.94%
Revenue Next 2Y26.63%
Revenue Next 3Y27.77%
Revenue Next 5YN/A
EBIT growth 1Y-70.32%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-866.87%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1032%
OCF growth 3YN/A
OCF growth 5YN/A